Navigation Links
JAG Media Holdings, Inc. Announces Update of the Status of its Proposed Acquisition of CardioGenics Inc.
Date:4/30/2009

BOCA RATON, Fla., April 30 /PRNewswire-FirstCall/ -- JAG Media Holdings, Inc. (OTC Bulletin Board: JAGH) announced today an update of the status of its proposed acquisition of CardioGenics Inc. by a to-be-created Canadian subsidiary of JAG Media, for which the parties entered into a Letter of Intent on March 12, 2009. Currently, the parties are attending to various closing matters such as the preparation and negotiation of the required documents in connection with the acquisition, preparation of the required audited financial statements for CardioGenics and establishment of the two Canadian subsidiaries of JAG Media required in connection with the transaction. Both parties are dedicating their full resources to execute all the matters in preparation for closing. Based upon the current status of the various closing matters being attended to by the parties, the parties now project a closing date of May 29, 2009.

Notwithstanding the Letter of Intent, there is no assurance that the definitive documentation called for in the Letter of Intent will ever be executed, or if executed, that the proposed transaction between JAG Media and CardioGenics will be consummated. Further, to the extent that definitive agreements are reached, no assurances can be given that any such agreements will be entered into consistent with the current expectations of JAG Media and CardioGenics, as contemplated by the terms of the Letter of Intent.

About JAG Media Holdings, Inc.

JAG Media Holdings, Inc. is a provider of Internet-based equities research and financial information that offers its subscribers a variety of stock market research, news and analysis, including "JAG Notes", the Company's flagship early morning consolidated research product.

About CardioGenics Inc.

CardioGenics develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. CardioGenics has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development by CardioGenics, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, CardioGenics has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. CardioGenics' principal offices are located in Mississauga, Ontario, Canada.


'/>"/>
SOURCE JAG Media Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Center to Expose and Close Animal Factories to Hold Media Teleconference Tomorrow to Discuss Smithfield Operations, Connection to Swine Flu, Health and Enviro Impacts
2. AUDIO from Medialink and the McKesson Settlement Administrator: McKesson Settlement
3. BioTech Medical Well-Positioned to Immediately Respond to Swine Flu Emergency with SDC-Based SpectraSan 24 Disinfectant
4. Locum Leaders Links Physicians to New Jobs and Clinical Education Through Social Media
5. Media Urged to Correct Inaccurate References to Swine Flu
6. Media registration now open for TCT 2009
7. Dr. David Williams Scoops National Media on PSA Effectiveness -- by 17 Years
8. AUDIO from Medialink and Prescription Solutions: Prescription Solutions - A Drug Interaction Alert
9. GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care
10. AdEx Media Introduces RezActiv(TM)
11. Media Statement on Lechuza Polo Team Incident
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology: